SOLARA ACTIVE PHARMA SCIENCES LIMITED — Regulatory Filings 2019

Aug 5, 2019

==> picture [60 x 54] intentionally omitted <==

==> picture [109 x 32] intentionally omitted <==

Communication Address: Solara Active Pharma Sciences Limited Batra Centre No. 28, Sardar Patel Road, Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700, 22207500 Fax: +91 44 22350278

August 5, 2019

The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400 001

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051

Scrip Code: 541540

Scrip Code: SOLARA

Dear Sir / Madam,

Sub: Intimation of Analysts / Institutional Investors Conference Call

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Tuesday, August 13, 2019 to discuss its QI financial results. The conference call details are as follows:

Event		Date & TimePhone Numbers
Post Results QI FY20Confrence Call	August1ST	13, 2019 at 03:00 p.m. +91 22 62801346+91 22 71158247

URL for prior (early) registration

h l tps:/ /s rvi ccs.chorusoall. in/Diamon dPassRcgistraLi n/regi stcr?confrmationN umber[=] 91845 &link Secuity tring==273ei2cS

This is for your information and records.

Thanking you,

Yours faithfully,

F r Solara Active Pharma Sciences Limited �� S. Murali Krishna Company Secretary

==> picture [84 x 84] intentionally omitted <==

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai- 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942